Delirium Care Assistant Assessment • Prevention • Cause Reversal • Management v1.2.1 · Copyright © 2026 Prof. Jyotirmay Kirtania · Licensed under GNU GPL v3
Session only
Patient & clinician information optional

This is a scope/safety gate, not a mandatory patient identifier. If age is entered, adult status is derived automatically. This tool is for adults; paediatric delirium requires a separate validated pathway (e.g. CAPD, pCAM-ICU, psCAM-ICU per local policy) and is not implemented here.

Device date & time—
Local timezone—
Assessment timestamp—
 

Local retention may expose patient information to other users of this device. Default is session-only memory that clears when the browser session closes.

Confusion Assessment Method (CAM)[1,2]

A deeply unresponsive or comatose patient is not assessable for delirium at that moment.

Feature 1 — Acute onset or fluctuating course

Acute change from baseline
Fluctuation during day / between observations

Feature 1: not assessed

Feature 2 — Inattention

Feature 3 — Disorganised thinking

Feature 4 — Altered level of consciousness

CAM: incomplete
Enter feature responses to compute a result.

CAM is not a severity score. A positive result supports delirium but still requires clinical diagnosis and evaluation of cause. A negative result at one time does not exclude later or fluctuating delirium.

Do not infer subtype from one isolated activity rating or RASS value.

4AT — Rapid Delirium & Cognitive Screen[3,4]

Item 1 — Alertness
Item 2 — AMT4 (age, date of birth, place, year)

AMT4: not assessed. Blank fields are never counted as correct.

Item 3 — Attention (months of the year backwards)
Item 4 — Acute change or fluctuating course

Significant change/fluctuation in alertness, cognition or mental function within the preceding 2 weeks and still evident in the last 24 hours.

4AT: incomplete
Complete all four items for interpretation. Blank items are not scored as zero.

HELP-Informed Care-Domain Assessment[5,6]

HELP is a multicomponent delirium-prevention and functional-maintenance programme. This tab records care needs and implementation; it is not a diagnostic test or validated numerical delirium score. This is a HELP-informed implementation, not an official licensed AGS CoCare HELP programme.

ABCDEF Bundle Assessment[7,8,9]

The ABCDEF bundle coordinates pain management, ventilator liberation, sedation, delirium care, mobility and family engagement. Completion is eligibility-dependent and is not a delirium diagnostic score.

Causes & Reversal

Active cause-identification and action tracker. Select a concern to record likelihood, evidence, a reversal action and an owner. A fixed investigation panel is not recommended for every patient.[8,10]

Cause–action tracker

No causes flagged yet.

Management Plan

Medication is subordinate to reversible-cause treatment, environmental and behavioural measures, comfort needs and immediate safety. Neither haloperidol nor dexmedetomidine appears merely because CAM or 4AT is positive.[8,9,13]

1. Immediate safety and distress

2. Cause-specific treatment

Unresolved causes from the Causes & Reversal tab appear here.

3. Multicomponent non-pharmacological care

4. Medication & sedation considerations

Do not call either drug "treatment of delirium." Haloperidol is symptom control for severe delirium manifestations; dexmedetomidine is sedation to facilitate safe ICU care or ventilator liberation. Antipsychotics do not routinely shorten delirium, improve survival, or correct the underlying cause.[13]

5. Monitoring & reassessment

6. Communication & disposition

Assessment timeline

No archived episodes yet. Use "New reassessment" to archive the current assessment.

Report

—

This report records a clinical assessment and care plan. Screening results require clinical interpretation. Not a medical device; no regulatory approval or official endorsement is claimed.

References & About

Offline-first clinical documentation and decision-support tool for qualified healthcare professionals caring for adults. It does not replace clinical diagnosis, neurological examination, collateral history, institutional protocols, prescribing safeguards, or consultant review.

Local configuration (implementer-editable)

These values are locally configurable metadata. They do not claim universal applicability of locally configured doses or maximums.

Licensing & attribution

Application licence

Delirium Care Assistant v1.2.1 — Copyright © 2026 Prof. Jyotirmay Kirtania.
This program is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation, either version 3 of the License, or (at your option) any later version.
This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the GNU General Public License for more details.
A copy of the GNU General Public License version 3 is available at https://www.gnu.org/licenses/gpl-3.0.html.

Separate or adapted pathways

Generic adult delirium pathways may be insufficient for: alcohol / benzodiazepine / opioid withdrawal, drug intoxication, toxic syndromes, catatonia, primary psychosis, mania, terminal/end-of-life delirium, paediatric delirium, persistent coma, severe unresponsiveness, or major acute neurological catastrophe. These must not be funnelled into routine antipsychotic treatment.

Automated self-tests

not run

Confirm